Aspen Pharmacare Holdings Limited (APN.JO) share price & analysis

JSE · Healthcare · Drug Manufacturers - Specialty & Generic

$14,412

Price at previous close. Open the live page for real-time data.

Key statistics

Market cap
P/E ratio
P/B ratio
P/S ratio
Dividend yield
Return on equity
Net margin
EPS (TTM)
Beta0.346
52-week range

About Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited is a global pharmaceutical entity that develops, manufactures, and distributes a wide array of specialized and branded medicinal products. The company operates through two primary segments: Commercial Pharmaceuticals and Manufacturing. Its diverse product portfolio encompasses essential anesthetic agents, such as general anesthetics, muscle relaxants, and topical preparations. Aspen also provides a comprehensive suite of thrombosis treatments, including various injectable anticoagulants like low molecular weight heparins, Xa inhibitors, and other heparin derivatives. Beyond these, the firm markets numerous regional consumer, prescription, and over-the-counter brands, such as Circadin for sleep, Foxair for respiratory ailments, Maltofer as an iron supplement, Mybulen for pain management, and Zyloric for gout. Additionally, Aspen produces active pharmaceut…

Frequently asked questions

What is Aspen Pharmacare Holdings Limited's P/E ratio?

Aspen Pharmacare Holdings Limited's trailing price-to-earnings (P/E) ratio is not currently available.

Does Aspen Pharmacare Holdings Limited pay a dividend?

Aspen Pharmacare Holdings Limited does not currently show a trailing dividend yield.

What is APN.JO's market capitalisation?

Aspen Pharmacare Holdings Limited's market cap is approximately —.

Open the live APN.JO analysis →

Educational data only — not financial advice. Figures from Financial Modeling Prep, updated periodically. Verify before acting.